Kortaro Tanaka

Summary

Affiliation: University of Toyama
Country: Japan

Publications

  1. ncbi Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial
    Kortaro Tanaka
    Department of Neurology, Toyama University Hospital, 2630 Sugitani, Toyama, Toyama, 930 0194, Japan
    Stroke 39:2052-8. 2008
  2. ncbi Clinical and transesophageal echocardiographic variables for prediction of thromboembolic events in patients with nonvalvular atrial fibrillation at low-intermediate risk
    Etsuko Sasahara
    Department of Neurology, Toyama University Hospital, Toyama, Japan
    J Cardiol 60:484-8. 2012
  3. ncbi Transesophageal echocardiographic findings are independent and relevant predictors of ischemic stroke in patients with nonvalvular atrial fibrillation
    Shutaro Takashima
    Department of Neurology, Toyama University Hospital, Toyama, Japan
    J Clin Neurol 8:170-6. 2012
  4. ncbi Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation
    Keiko Nakagawa
    Second Department of Internal Medicine, University of Toyama, Toyama, Japan
    Am J Cardiol 107:912-6. 2011
  5. ncbi Predictors of poor outcome in patients with acute cerebral infarction
    Nobuhiro Dougu
    Department of Neurology, Toyama University Hospital, Toyama, Japan
    J Clin Neurol 7:197-202. 2011
  6. ncbi One-year atherothrombotic vascular events rates in outpatients with recent non-cardioembolic ischemic stroke: the EVEREST (Effective Vascular Event REduction after STroke) registry
    Norihiro Suzuki
    Department of Neurology, Keio University School of Medicine, Shinjuku ku, Tokyo, Japan
    J Stroke Cerebrovasc Dis 21:245-53. 2012
  7. ncbi Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE
    Hiroshi Inoue
    Department of Internal Medicine, University of Toyama, Toyama, Japan
    Circ J 74:650-4. 2010
  8. ncbi Study of hemostatic biomarkers in acute ischemic stroke by clinical subtype
    Koji Hirano
    Department of Neurology, University of Toyama, Toyama, Japan
    J Stroke Cerebrovasc Dis 21:404-10. 2012
  9. ncbi The Japan Thrombosis Registry for Atrial Fibrillation, Coronary or Cerebrovascular Events (J-TRACE): a nation-wide, prospective large cohort study; the study design
    Hideki Origasa
    Division of Biostatistics and Clinical Epidemiology, University of Toyama School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930 0194, Japan
    Circ J 72:991-7. 2008
  10. ncbi Cerebral microbleeds identified by diffusion weighted MR imaging in a case of acute ischemic stroke
    Yoshiharu Taguchi
    Department of Neurology, Toyama University Hospital, Toyama
    Intern Med 46:1275-6. 2007

Detail Information

Publications21

  1. ncbi Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial
    Kortaro Tanaka
    Department of Neurology, Toyama University Hospital, 2630 Sugitani, Toyama, Toyama, 930 0194, Japan
    Stroke 39:2052-8. 2008
    ..EPA significantly suppressed the incidence of coronary events in previous analysis. Herein, we investigated the effects of EPA on the primary and secondary prevention of stroke...
  2. ncbi Clinical and transesophageal echocardiographic variables for prediction of thromboembolic events in patients with nonvalvular atrial fibrillation at low-intermediate risk
    Etsuko Sasahara
    Department of Neurology, Toyama University Hospital, Toyama, Japan
    J Cardiol 60:484-8. 2012
    ..There is no clear consensus about antithrombotic treatment in atrial fibrillation (AF) patients at low-intermediate thromboembolic risk. Transesophageal echocardiography (TEE) is useful for prediction of thromboembolic events in AF...
  3. ncbi Transesophageal echocardiographic findings are independent and relevant predictors of ischemic stroke in patients with nonvalvular atrial fibrillation
    Shutaro Takashima
    Department of Neurology, Toyama University Hospital, Toyama, Japan
    J Clin Neurol 8:170-6. 2012
    ..However, it remains to be determined which of these factors might be more relevant for evaluation of the risk of stroke in each patient...
  4. ncbi Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation
    Keiko Nakagawa
    Second Department of Internal Medicine, University of Toyama, Toyama, Japan
    Am J Cardiol 107:912-6. 2011
    ..Long-term mortality, cardiac events, and stroke risk were >8 times higher when decreased eGFR (<60 ml/min/1.73 m(2)) was present with higher CHADS(2) score (≥2)...
  5. ncbi Predictors of poor outcome in patients with acute cerebral infarction
    Nobuhiro Dougu
    Department of Neurology, Toyama University Hospital, Toyama, Japan
    J Clin Neurol 7:197-202. 2011
    ..We investigated whether the D-dimer level on admission and other clinical characteristics could be used to predict the poor outcome of patients with acute CI...
  6. ncbi One-year atherothrombotic vascular events rates in outpatients with recent non-cardioembolic ischemic stroke: the EVEREST (Effective Vascular Event REduction after STroke) registry
    Norihiro Suzuki
    Department of Neurology, Keio University School of Medicine, Shinjuku ku, Tokyo, Japan
    J Stroke Cerebrovasc Dis 21:245-53. 2012
    ..Our aims were to investigate 1-year atherothrombotic vascular event rates and to assess the risk factors for recurrent ischemic stroke in this population...
  7. ncbi Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE
    Hiroshi Inoue
    Department of Internal Medicine, University of Toyama, Toyama, Japan
    Circ J 74:650-4. 2010
    ..Whether such a difference exists for Japanese patients with AF is unclear, so data from J-TRACE were used to investigate this issue...
  8. ncbi Study of hemostatic biomarkers in acute ischemic stroke by clinical subtype
    Koji Hirano
    Department of Neurology, University of Toyama, Toyama, Japan
    J Stroke Cerebrovasc Dis 21:404-10. 2012
    ..We studied the usefulness of hemostatic biomarkers in assessing the pathology of thrombus formation, subtype diagnosis, prognosis in the acute phase of cerebral infarction, and differences between various hemostatic biomarkers...
  9. ncbi The Japan Thrombosis Registry for Atrial Fibrillation, Coronary or Cerebrovascular Events (J-TRACE): a nation-wide, prospective large cohort study; the study design
    Hideki Origasa
    Division of Biostatistics and Clinical Epidemiology, University of Toyama School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930 0194, Japan
    Circ J 72:991-7. 2008
    ....
  10. ncbi Cerebral microbleeds identified by diffusion weighted MR imaging in a case of acute ischemic stroke
    Yoshiharu Taguchi
    Department of Neurology, Toyama University Hospital, Toyama
    Intern Med 46:1275-6. 2007
  11. ncbi Boule musculaire associated with cervical spondylosis
    Yoshiharu Taguchi
    The Department of Neurology, Toyama University Hospital
    Intern Med 46:329. 2007
  12. ncbi Bilateral subthalamic deep brain stimulation for camptocormia associated with Parkinson's disease
    Takashi Asahi
    Department of Neurosurgery University of Toyama, Toyama, Japan
    Stereotact Funct Neurosurg 89:173-7. 2011
    ..Although deep brain stimulation was in some cases not effective against camptocormia, it is unclear in which types of patients it was effective in treating camptocormia...
  13. ncbi Significant impairment of left atrial function in patients with cardioembolic stroke caused by paroxysmal atrial fibrillation
    Yoshiharu Taguchi
    Department of Neurology at Toyama University Hospital, Toyama, Japan
    Intern Med 49:1727-32. 2010
    ..The present study examined the differences in echocardiographic findings between patients with CE caused by Paf (the Paf-CE group) and those with non-cardiogenic embolic ischemic stroke (the Non-CE group)...
  14. ncbi Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation
    Shinichiro Uchiyama
    Department of Neurology, Tokyo Women s Medical University School of Medicine, Shinjuku ku, Tokyo, Japan
    J Stroke Cerebrovasc Dis 21:165-73. 2012
    ..We also discuss precautions for the use of dabigatran and future perspectives with a view to reducing the risk of stroke with new oral anticoagulants, including factor Xa inhibitors in AF patients...
  15. ncbi [A survey of psychiatrists to determine their level of familiarity with anti-N-methyl-D-aspartate receptor encephalitis]
    Yoshiharu Taguchi
    Department of Neurology, Toyama University Hospital, Japan
    Brain Nerve 64:1341-5. 2012
    ..05). The present survey revealed low levels of familiarity of psychiatrists with anti-NMDAR encephalitis, and this highlights the importance of further improving the awareness of psychiatrists about the concept of anti-NMDAR encephalitis...
  16. ncbi [A case of anti-N-methyl-D-aspartate receptor encephalitis with ovarian teratoma showing excellent recovery with decreasing of anti-N-methyl-D-aspartate receptor antibody]
    Yoshiharu Taguchi
    Department of Neurology, Toyama University Hospital
    Rinsho Shinkeigaku 51:499-504. 2011
    ..The patient was hence diagnosed as having anti-NMDAR encephalitis with ovarian teratoma Serial analysis show that the antibodies against NMDAR decreased with improvement of symptoms after the immunotherapy including DFPP treatment...
  17. ncbi Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry
    Shinichiro Uchiyama
    Department of Neurology, Tokyo Women s Medical University, Tokyo, Japan
    J Stroke Cerebrovasc Dis 19:190-7. 2010
    ....
  18. ncbi Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects
    Shigeaki Suzuki
    Department of Neurology, Keio University School of Medicine, Shinjuku ku, Tokyo, Japan
    J Cereb Blood Flow Metab 29:464-79. 2009
    ..Taken together, the information suggests that IL-6 plays a double role in cerebral ischemia, as an inflammatory mediator during the acute phase and as a neurotrophic mediator between the subacute and prolonged phases...
  19. ncbi Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats
    Shigeaki Suzuki
    Department of Neurology, School of Medicine, Keio University, Shinjuku ku, Tokyo, Japan
    J Cereb Blood Flow Metab 25:685-93. 2005
    ..Early induction of phosphorylated Stat3 was significantly detected on the ischemic side in the high-LIF group after LIF injection. Exogenous LIF attenuates ischemic brain injury by activating cytokine signaling through LIFR/gp130...
  20. ncbi A novel voltage-sensitive Na(+) and Ca(2+) channel blocker, NS-7, prevents suppression of cyclic AMP-dependent protein kinase and reduces infarct area in the acute phase of cerebral ischemia in rat
    Kortaro Tanaka
    Department of Neurology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku ku, Tokyo 160 8582, Japan
    Brain Res 924:98-108. 2002
    ..These data clearly indicate that NS-7 provides very efficient neuroprotection in the acute phase of cerebral ischemia, and sustains the normal function of PKA...
  21. ncbi Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002
    Kortaro Tanaka
    Department of Neurology, School of Medicine, Keio University, Shinanomachi, Tokyo
    Intern Med 44:560-6. 2005
    ....